Novo Nordisk positions

The Novo Nordisk business is based on a clear vision, a strong set of core values and a consistent corporate governance model.

As a natural consequence, we have formulated positions on issues of relevance to our business and our role as a global corporate citizen:

  • Access to health
  • Animal experimentation
  • Climate change
  • Clinical trials
  • Gene technology
  • Human rights
  • Intellectual property rights and patenting
  • Use of non-human primates
  • Stem cells

The positions presented express our views as well as the context and the background for the position.

Below, Novo Nordisk contact persons are named, from whom more information on each issue can be obtained.

Media representatives are kindly asked to contact our Media Relations Team.

PositionContacts

Access to health

Lene Andersen
Vice President,
Global Diabetes Partnerships
+45 4442 1893


Climate

Susanne Stormer
Vice President,
Global TBL Management
+45 4442 4479


Animal experimentation

Mads Krogsgaard Thomsen
Executive Vice President
and Chief Science Officer
+45 4442 3988


Gene technology

Steen Weber Jensen
Vice President
Manufacturing Development
+45 4442 2979


Human rights

Lene Andersen
Vice President,
Global Diabetes Partnerships
+45 4442 1893


IPR and patenting

Lars Kellberg
Vice President,
Business Development and Patents
+45 4442 1822


Stem cells

Mads Krogsgaard Thomsen
Executive Vice President
and Chief Science Officer
+45 4442 3988


Use of non-human primates

Mads Krogsgaard Thomsen
Executive Vice President
and Chief Science Officer
+45 4442 3988